Clinical Trial Update: Expanded Access Treatment Protocol With DCA for Patients With PDCD

View source ↗

Summary

An Expanded Access treatment protocol using dichloroacetate (DCA) for patients with Pyruvate Dehydrogenase Complex Deficiency is available, sponsored by Saol Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pyruvate Dehydrogenase Complex Deficiency

Drugs mentioned

• DCA (dichloroacetate)

Snippet

Sponsor: Saol Therapeutics Inc | Conditions: Pyruvate Dehydrogenase Complex Deficiency | Status: AVAILABLE